雅虎香港 搜尋

搜尋結果

1. www.eisai.com › news › 2024EISAI TO DIVEST RIGHTS FOR MERISLON® AND MYONAL® IN ...

   www.eisai.com › news › 2024

   • 網頁紀錄

   2024年3月29日 · Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) announced today that it has entered into an agreement to divest its rights for vertigo and equilibrium disturbance treatment Merislon ® (generic name: betahistine mesilate) and muscle relaxant ®

   • EISAI TO DIVEST RIGHTS FOR MUSCLE RELAXANT MYONAL® AND VERTIGO AND EQUILIBRIUM DISTURBANCE TREATMENT MERISLON® IN ASIA TO DKSH

     Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, ...

2. medical.eisai.jp › products › mrsメリスロン錠6mg | メリスロン | エーザイ Medical.eisai.jp 医 ...

   medical.eisai.jp › products › mrs

   • 網頁紀錄

   製品概要. ※ご使用にあたっては 電子添文 をご確認ください. 剤形名. メリスロン錠6mgの添付文書、インタビューフォームなどの情報を掲載しています。 エーザイの医療関係者向け情報サイトです。 医療用医薬品を適正にご使用いただくための情報を提供しています。

3. www.rad-ar.or.jp › siori › englishMerislon Tablets 6mg | Kusuri-no-Shiori (Drug Information Sheet)

   www.rad-ar.or.jp › siori › english

   Brand name. Merislon Tablets 6mg. Eisai Co., Ltd. Word. 日本語. The information on this sheet is based on approvals granted by the Japanese regulatory authority. Approval details may vary by country. Medicines have adverse reactions (risks) as well as efficacies (benefits). It is important to minimize adverse reactions and maximize efficacy.

4. www.kegg.jp › medicus-bin › japic_med医療用医薬品 : メリスロン (メリスロン錠6mg 他) - KEGG

   www.kegg.jp › medicus-bin › japic_med

   • 網頁紀錄

   東京都文京区小石川4-6-10. めまい・平衡障害治療剤; 総称名:メリスロン; 一般名:ベタヒスチンメシル酸塩; 販売名:メリスロン錠6mg, メリスロン錠12mg; 製造会社:エーザイ.

   • 一般名: ベタヒスチンメシル酸塩
   • 総称名: メリスロン

   • 欧文一般名: Betahistine Mesilate
   • 薬効分類名: めまい・平衡障害治療剤

5. www.eisai.com › news › 2022EISAI TO DIVEST RIGHTS FOR MUSCLE RELAXANT MYONAL® AND ...

   www.eisai.com › news › 2022

   • 網頁紀錄

   2022年11月7日 · Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) announced today that it has entered into an agreement to divest its rights for muscle relaxant Myonal ® (generic name: eperisone hydrochloride) and vertigo and equilibrium disturbance treatment Merislon ® (generic name: betahistine mesilate) in Asia (9 countries/regions*) to a subs...

6. en.acnnewswire.com › press-release › englishEisai to Divest Rights for Merislon and Myonal in Japan to ...

   en.acnnewswire.com › press-release › english

   • 網頁紀錄

   2024年3月29日 · TOKYO, Mar 29, 2024 - (JCN Newswire) - Eisai Co., Ltd. announced today that it has entered into an agreement to divest its rights for vertigo and equilibrium disturbance treatment Merislon® (generic name: betahistine mesilate) and muscle relaxant Myonal® (generic name: eperisone hydrochloride) in Japan to Kaken Pharmaceutical Co., Ltd.

7. www.jcnnewswire.com › english › pressreleaseEisai to Divest Rights for Merislon and Myonal in Japan to ...

   www.jcnnewswire.com › english › pressrelease

   • 網頁紀錄

   2024年3月29日 · Merislon and Myonal have been widely used by patients in Japan for a long time since their launch in 1969 and 1983, respectively. Eisai has determined that divesting rights for these products to Kaken, which has strengths in the products’ disease areas, is the most optimal choice to ensure them to continue contributing to a greater number of ...